中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
In-situ trichosanthin-IL2/pectin dynamic hydrogel activates dendritic cells and reverses T cell exhaustion for post-operative cancer therapy

文献类型:期刊论文

作者Gu, Zeyun7,8,9; Chen, Guihua6; Gao, Nan4,5; Yao, Shuo3; Zhang, Xiaoru6; Xu, Quangang7; Xiong, Wei6; Liu, Lin7; Liu, Qin6; Yin, Dan8,9
刊名CHEMICAL ENGINEERING JOURNAL
出版日期2025-02-01
卷号505页码:12
关键词Trichosanthin IL2 Hydrogel Postoperative administration Cancer immunotherapy Dendritic cells
ISSN号1385-8947
DOI10.1016/j.cej.2025.159426
英文摘要Postoperative recurrence and metastasis of triple-negative breast cancer (TNBC) remain major clinical challenges due to immunosuppression and poor immune recognition of residual cancer cells. Here, we present a novel polysaccharide-protein hydrogel implant, composed of a trichosanthin (TCS)-IL2 fusion protein crosslinked with oxidized pectin, designed for sustained local immunotherapy following tumor resection. TCS is a plant-derived protein with immune-stimulatory properties. This in-situ forming gel (termed TL-pectin gel) delivers the TCS-IL2 (TL) protein to enhance dendritic cell (DC) maturation, improve antigen presentation, and reverse T-cell exhaustion, thereby stimulating tumor-specific cytotoxicity. In a mouse breast cancer model, the TL-pectin hydrogel effectively inhibited local tumor recurrence and reduced lung and brain metastases, demonstrating its potential to improve postoperative outcomes. Mechanistic studies indicated that TCS activated the NF-kappa B pathway, enhanced cytokine secretion and CD8+ T-cell differentiation, and IL2 maintained T-cell proliferation and activity. The hydrogel showed excellent biocompatibility and functioned as a controlled-release system to form a localized immunostimulatory microenvironment. This study suggests that TL-pectin gel is a promising candidate for clinical translation, offering a potential approach for adjuvant cancer immunotherapy.
资助项目National Key Research and Development Program of China, China[2021YFC2400600] ; National Key Research and Development Program of China, China[2022YFE0203600] ; NFSC[81925035] ; NFSC[82341232] ; Department of Science and Technology of Guangdong Province[2019B090904008] ; Department of Science and Technology of Guangdong Province[2021B0909050003] ; Chinese Academy of Sciences President's International Fellowship Initiative[2024VBB0004] ; Scientific Innovation Group Project in Zhongshan[LJ2021001]
WOS研究方向Engineering
语种英语
WOS记录号WOS:001401944600001
出版者ELSEVIER SCIENCE SA
源URL[http://119.78.100.183/handle/2S10ELR8/315917]  
专题新药研究国家重点实验室
通讯作者Zhu, Xiao-Ming; Huang, Yongzhuo
作者单位1.NMPA Key Lab Qual Res & Evaluat Pharmaceut Excipie, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
3.Guangdong Pharmaceut Univ, Guangzhou, Peoples R China
4.Macau Univ Sci & Technol, Fac Med, Sch Pharm, Taipa 999078, Macao, Peoples R China
5.Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa 999078, Macao, Peoples R China
6.Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangdong Clin Res Acad Chinese Med, Artemisinin Res Ctr, Guangzhou 510450, Peoples R China
7.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528437, Peoples R China
8.Macau Univ Sci & Technol, Fac Chinese Med, Taipa 999078, Macao, Peoples R China
9.Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa 999078, Macao, Peoples R China
推荐引用方式
GB/T 7714
Gu, Zeyun,Chen, Guihua,Gao, Nan,et al. In-situ trichosanthin-IL2/pectin dynamic hydrogel activates dendritic cells and reverses T cell exhaustion for post-operative cancer therapy[J]. CHEMICAL ENGINEERING JOURNAL,2025,505:12.
APA Gu, Zeyun.,Chen, Guihua.,Gao, Nan.,Yao, Shuo.,Zhang, Xiaoru.,...&Huang, Yongzhuo.(2025).In-situ trichosanthin-IL2/pectin dynamic hydrogel activates dendritic cells and reverses T cell exhaustion for post-operative cancer therapy.CHEMICAL ENGINEERING JOURNAL,505,12.
MLA Gu, Zeyun,et al."In-situ trichosanthin-IL2/pectin dynamic hydrogel activates dendritic cells and reverses T cell exhaustion for post-operative cancer therapy".CHEMICAL ENGINEERING JOURNAL 505(2025):12.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。